NCT01010893
Source recordAI-normalized
Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons
The clinical trial assessed the tolerability and immunogenicity of the FLUVAL P monovalent influenza vaccine in adults and elderly individuals. Conducted by Fluart Innovative Vaccine Ltd, the study aimed to verify the vaccine's efficacy and safety profile, particularly in the context of pandemic influenza prevention.
AI analysis
Indication: Influenza
Modality: vaccine
Target: Influenza
Sponsor: Fluart Innovative Vaccine Ltd, Hungary
Source URL: ClinicalTrials.gov
Source updated: May 21, 2012
Ingested: May 30, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Influenza
View original source fields
Condition raw: Influenza
Condition normalized: Influenza
Modality raw: Influenza
Modality normalized: vaccine
Target raw: Influenza
Target normalized: Influenza